Roger Susi Sells 5,000 Shares of iRadimed (NASDAQ:IRMD) Stock

Key Points

• iRadimed CEO Roger Susi sold 5,000 shares of the company's stock for approximately $350,950 at an average price of $70.19, reducing his ownership by 0.21%.
• The company declared a quarterly dividend of $0.17, representing an annualized rate of $0.68 and a yield of 1.0%.
• Institutional investors hold 92.34% of iRadimed's stock, with several firms boosting their stakes significantly in the recent quarter.

iRadimed Corporation (NASDAQ:IRMD - ) CEO Roger Susi sold 5,000 shares of the firm's stock in a transaction that occurred on Wednesday, October 1st. The shares were sold at an average price of $70.19, for a total transaction of $350,950.00. Following the transaction, the chief executive officer directly owned 2,347,500 shares in the company, valued at approximately $164,771,025. The trade was a 0.21% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

iRadimed Price Performance

IRMD traded up $0.66 during midday trading on Thursday, hitting $71.08. 43,567 shares of the company's stock traded hands, compared to its average volume of 45,215. iRadimed Corporation has a one year low of $46.86 and a one year high of $74.43. The company has a market cap of $904.14 million, a PE ratio of 43.88 and a beta of 1.02. The stock's fifty day simple moving average is $69.41 and its 200-day simple moving average is $60.05.

iRadimed Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, August 28th. Stockholders of record on Monday, August 18th were given a $0.17 dividend. The ex-dividend date of this dividend was Monday, August 18th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.0%. iRadimed's dividend payout ratio (DPR) is currently 41.98%.

Hedge Funds Weigh In On iRadimed

A number of institutional investors have recently modified their holdings of IRMD. Jump Financial LLC boosted its stake in iRadimed by 4.9% during the first quarter. Jump Financial LLC now owns 4,300 shares of the medical equipment provider's stock worth $226,000 after buying an additional 200 shares in the last quarter. First Horizon Advisors Inc. boosted its stake in iRadimed by 78.7% during the first quarter. First Horizon Advisors Inc. now owns 513 shares of the medical equipment provider's stock worth $27,000 after buying an additional 226 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in iRadimed by 5.1% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,811 shares of the medical equipment provider's stock worth $252,000 after buying an additional 234 shares in the last quarter. Martingale Asset Management L P boosted its stake in iRadimed by 2.4% during the first quarter. Martingale Asset Management L P now owns 12,831 shares of the medical equipment provider's stock worth $673,000 after buying an additional 300 shares in the last quarter. Finally, State of Wyoming boosted its stake in iRadimed by 11.3% during the first quarter. State of Wyoming now owns 3,013 shares of the medical equipment provider's stock worth $158,000 after buying an additional 307 shares in the last quarter. Institutional investors own 92.34% of the company's stock.

About iRadimed

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.